<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Late Night Pyq Pyt Marathon (Obg 7)   2025 03 08</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Late Night Pyq Pyt Marathon (Obg 7)   2025 03 08</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                60 Questions | 240 Total Marks | 70 min Duration | ~70.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 60 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 70 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 60</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Late Night Pyq Pyt Marathon (Obg 7)   2025 03 08 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 60</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 60 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "The non-contraceptive uses of oral contraceptives include all of the following except? (INICET NOV 2022)", "options": [{"label": "A", "text": "Reduction in the risk of ovarian cancer", "correct": false}, {"label": "B", "text": "Ectopic pregnancy", "correct": false}, {"label": "C", "text": "Protection against sexually transmitted diseases including HIV", "correct": true}, {"label": "D", "text": "Reduction in the risk of endometrial cancer", "correct": false}], "correct_answer": "C. Protection against sexually transmitted diseases including HIV", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. C) Protection against sexually transmitted diseases including HIV</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The non-contraceptive benefits of combined oral contraceptive pills (COCPs) include:</li><li>â€¢ Reduction in the risk of ovarian cancer : COCPs reduce the incidence of ovarian cancer. Reduction in the risk of endometrial cancer : COCPs lower the incidence of endometrial malignancy. Reduction in the incidence of ectopic pregnancy : COCPs decrease the likelihood of ectopic pregnancies by preventing ovulation and thickening cervical mucus.</li><li>â€¢ Reduction in the risk of ovarian cancer : COCPs reduce the incidence of ovarian cancer.</li><li>â€¢ Reduction in the risk of ovarian cancer</li><li>â€¢ Reduction in the risk of endometrial cancer : COCPs lower the incidence of endometrial malignancy.</li><li>â€¢ Reduction in the risk of endometrial cancer</li><li>â€¢ Reduction in the incidence of ectopic pregnancy : COCPs decrease the likelihood of ectopic pregnancies by preventing ovulation and thickening cervical mucus.</li><li>â€¢ Reduction in the incidence of ectopic pregnancy</li><li>â€¢ However, COCPs do not provide protection against sexually transmitted diseases (STDs), including HIV.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Reduction in the risk of ovarian cancer : COCPs are known to reduce the incidence of ovarian cancer.</li><li>â€¢ Option A. Reduction in the risk of ovarian cancer</li><li>â€¢ Option B. Ectopic pregnancy : COCPs lower the risk of ectopic pregnancy by preventing ovulation and thickening the cervical mucus.</li><li>â€¢ Option B. Ectopic pregnancy</li><li>â€¢ Option D. Reduction in the risk of endometrial cancer : COCPs decrease the risk of endometrial cancer.</li><li>â€¢ Option D. Reduction in the risk of endometrial cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Combined oral contraceptive pills do not provide protection against sexually transmitted diseases (STDs), including HIV.</li><li>âž¤ Ref: Williamâ€™s textbook of gynecology 3 rd edition pg 124, Duttaâ€™s textbook of gynecology 6 th edition pg 489</li><li>âž¤ Ref: Williamâ€™s textbook of gynecology 3 rd edition pg 124, Duttaâ€™s textbook of gynecology 6 th edition pg 489</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Identify the finding shown in image given below: (FMGE JANUARY 2023)", "options": [{"label": "A", "text": "Stria Gravidarum", "correct": false}, {"label": "B", "text": "Linea Alba", "correct": false}, {"label": "C", "text": "Linea Nigra", "correct": true}, {"label": "D", "text": "Stria albicans", "correct": false}], "correct_answer": "C. Linea Nigra", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/19/untitled-1046_Xio1rZb.jpg"], "explanation_images": [], "explanation": "<p><strong>Ans. C) Linea Nigra</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ A hyperpigmented line from xiphisternum to pubic symphysis is Linea Nigra.</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Stria gravidarum : Stria gravidarum is a reddish stria of present pregnancy.</li><li>â€¢ Option A.</li><li>â€¢ Stria gravidarum</li><li>â€¢ Option B. Linea Alba : The midline of the anterior abdominal wall skin. It takes on dark brown-black pigmentation to form the linea nigra.</li><li>â€¢ Option B. Linea Alba</li><li>â€¢ Option D. Stria albicans : Stria albicans is a silvery stria of previous pregnancies.</li><li>â€¢ Option D.</li><li>â€¢ Stria albicans</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ A hyperpigmented line from xiphisternum to pubic symphysis is Linea Nigra.</li><li>âž¤ Ref: Page no 79, DC Duttaâ€™s Textbook of Obstetrics 8 th edition</li><li>âž¤ Ref: Page no 79, DC Duttaâ€™s Textbook of Obstetrics 8 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Drug contraindicated in asthma in PPH (Postpartum Hemorrhage) case? (NEET PG 2024)", "options": [{"label": "A", "text": "Methyl ergometrine", "correct": false}, {"label": "B", "text": "Carboprost", "correct": true}, {"label": "C", "text": "Misoprostol", "correct": false}, {"label": "D", "text": "Oxytocin", "correct": false}], "correct_answer": "B. Carboprost", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Carboprost</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Carboprost (PGF2 alpha) is contraindicated in patients with asthma due to its bronchoconstrictive effects.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following can be expected if division of zygote occurs between 8 â€“ 12 days after fertilization? (FMGE JANUARY 2023)", "options": [{"label": "A", "text": "Dichorionic Diamniotic", "correct": false}, {"label": "B", "text": "Dichorionic Monoamniotic", "correct": false}, {"label": "C", "text": "Monochorionic Monoamniotic", "correct": true}, {"label": "D", "text": "Conjoined twins", "correct": false}], "correct_answer": "C. Monochorionic Monoamniotic", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-113846.png"], "explanation": "<p><strong>Ans. C) Monochorionic Monoamniotic</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Dichorionic Diamniotic: Occurs when the division of the zygote happens within the first 3 days after fertilization.</li><li>â€¢ Option A. Dichorionic Diamniotic:</li><li>â€¢ Option B. Dichorionic Monoamniotic: This is not a typical classification in twin pregnancies.</li><li>â€¢ Option B. Dichorionic Monoamniotic:</li><li>â€¢ Option D. Conjoined twins: Result from the division of the zygote occurring after the 13th day of fertilization.</li><li>â€¢ Option D. Conjoined twins:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Monochorionic monoamniotic twins result from the division of the zygote occurring between 8 to 12 days after fertilization.</li><li>âž¤ Ref: Williams Textbook of Obstetrics 24 th edition page 893</li><li>âž¤ Ref:</li><li>âž¤ Williams Textbook of Obstetrics 24 th edition</li><li>âž¤ page 893</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "What is the minimum endometrial thickness on transvaginal ultrasonography, above which you perform a biopsy in a case of postmenopausal bleeding? (INICET NOV 2018)", "options": [{"label": "A", "text": "3 mm", "correct": false}, {"label": "B", "text": "4 mm", "correct": true}, {"label": "C", "text": "7 mm", "correct": false}, {"label": "D", "text": "9 mm", "correct": false}], "correct_answer": "B. 4 mm", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) 4 mm</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Post menopausal bleeding with a finding of endometrial thickness greater than 4 mm (5 mm or more) requires further evaluation, i.e., a biopsy of the endometrium. If the endometrial thickness is â‰¤4 mm, then malignancy is unlikely and the likely cause of bleeding being endometrial atrophy and there is no need of a biopsy. The most common cause of post-menopausal bleeding is atrophic endometritis</li><li>â€¢ Post menopausal bleeding with a finding of endometrial thickness greater than 4 mm (5 mm or more) requires further evaluation, i.e., a biopsy of the endometrium.</li><li>â€¢ If the endometrial thickness is â‰¤4 mm, then malignancy is unlikely and the likely cause of bleeding being endometrial atrophy and there is no need of a biopsy.</li><li>â€¢ The most common cause of post-menopausal bleeding is atrophic endometritis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In postmenopausal women with bleeding, an endometrial thickness greater than 4 mm on transvaginal ultrasonography should prompt further evaluation with an endometrial biopsy to rule out malignancy or other significant pathology.</li><li>âž¤ Ref: Williamâ€™s textbook of gynecology 3 rd edition pg 186, Duttaâ€™s textbook of gynecology 6 th edition pg 357</li><li>âž¤ Ref: Williamâ€™s textbook of gynecology 3 rd edition pg 186, Duttaâ€™s textbook of gynecology 6 th edition pg 357</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Drug of choice for malaria (plasmodium vivax) in pregnancy? (FMGE JANUARY 2024)", "options": [{"label": "A", "text": "Chloroquine + Primaquine", "correct": false}, {"label": "B", "text": "Chloroquine", "correct": true}, {"label": "C", "text": "Quinine", "correct": false}, {"label": "D", "text": "Artesunate", "correct": false}], "correct_answer": "B. Chloroquine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Chloroquine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Treatment of Malaria in Pregnancy</li><li>âž¤ Treatment of Malaria in Pregnancy</li><li>âž¤ Chloroquine â€“ 600 mg base P.O. followed by 300 mg 12 hours later. Then 300 mg daily for next 2 days. To prevent relapse during pregnancy, 300 mg is to be taken weekly until delivery. For radical cure, primaquine should be postponed until pregnancy is over. Parasites resistant to chloroquine should be given quinine under supervision. Patients with severe anemia may need blood transfusion. Folic acid 10 mg should be given daily to prevent megaloblastic anemia. Complicated malaria: Artesunate IV 2.4 mg/kg at 0, 12 and 24 hours, then daily thereafter. Oral therapy (2 mg/kg) is started when the patient is stable. Alternatively, Quinine IV followed by oral therapy is given.</li><li>âž¤ Chloroquine â€“ 600 mg base P.O. followed by 300 mg 12 hours later. Then 300 mg daily for next 2 days.</li><li>âž¤ To prevent relapse during pregnancy, 300 mg is to be taken weekly until delivery.</li><li>âž¤ For radical cure, primaquine should be postponed until pregnancy is over.</li><li>âž¤ Parasites resistant to chloroquine should be given quinine under supervision.</li><li>âž¤ Patients with severe anemia may need blood transfusion.</li><li>âž¤ Folic acid 10 mg should be given daily to prevent megaloblastic anemia.</li><li>âž¤ Complicated malaria: Artesunate IV 2.4 mg/kg at 0, 12 and 24 hours, then daily thereafter. Oral therapy (2 mg/kg) is started when the patient is stable.</li><li>âž¤ Alternatively, Quinine IV followed by oral therapy is given.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 35-year-old primigravida who conceived after in-vitro fertilization therapy came for an antenatal checkup at 38 weeks of gestation. Her obstetric history revealed that she was pregnant with DCDA twins. On examination, the first twin was found to be in a breech position and the maternal blood pressure was found to be greater than 140/90 mm Hg on two occasions with grade 1+ proteinuria. What should be done next? (NEET PG 2020)", "options": [{"label": "A", "text": "Monitor BP and terminate pregnancy if BP rises", "correct": false}, {"label": "B", "text": "Immediate Caesarean section", "correct": true}, {"label": "C", "text": "Terminate pregnancy at 40 weeks of gestation", "correct": false}, {"label": "D", "text": "Induce labor with PGE2 gel", "correct": false}], "correct_answer": "B. Immediate Caesarean section", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Immediate Caesarean section</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In cases of preeclampsia with twin pregnancies where the first twin is in a breech position at 38 weeks, immediate cesarean section is the recommended course of action.</li><li>âž¤ Ref: Page no 1778, Williams Obstetrics, 26 th edition</li><li>âž¤ Ref: Page no 1778, Williams Obstetrics, 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A pregnant woman at 36 weeks of gestation presents to you with complaints of feeling light-headedness and dizziness when she lies on her back and feels relieved if she lies on her side or when walks. What is the most likely reason behind this? (NEET PG 2023)", "options": [{"label": "A", "text": "Increased intracranial pressure", "correct": false}, {"label": "B", "text": "IVC compression", "correct": true}, {"label": "C", "text": "Heavy meals", "correct": false}, {"label": "D", "text": "Excessive venous pooling at the feet", "correct": false}], "correct_answer": "B. IVC compression", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) IVC compression</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The symptoms of light-headedness and dizziness that the pregnant woman experiences when lying on her back, which are relieved by lying on her side or walking, are indicative of inferior vena cava (IVC) compression. In the supine position during late pregnancy, the gravid uterus compresses the IVC, which can decrease venous return to the heart. This condition, known as supine hypotensive syndrome, leads to reduced cardiac output and can cause symptoms such as dizziness, light-headedness, and a decreased supply of oxygen and nutrients to vital organs.</li><li>â€¢ Supine Hypotensive Syndrome: This occurs when the enlarged uterus compresses the IVC, reducing venous return to the heart, leading to symptoms like dizziness and light-headedness. Relief by changing position: Symptoms are relieved when the woman lies on her side or walks because these positions alleviate the pressure on the IVC, improving venous return and cardiac output.</li><li>â€¢ Supine Hypotensive Syndrome: This occurs when the enlarged uterus compresses the IVC, reducing venous return to the heart, leading to symptoms like dizziness and light-headedness.</li><li>â€¢ Supine Hypotensive Syndrome:</li><li>â€¢ Relief by changing position: Symptoms are relieved when the woman lies on her side or walks because these positions alleviate the pressure on the IVC, improving venous return and cardiac output.</li><li>â€¢ Relief by changing position:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Increased intracranial pressure: This would present with symptoms such as headache, vomiting, visual disturbances, and altered mental status, not positional dizziness relieved by lying on the side.</li><li>â€¢ Option A. Increased intracranial pressure:</li><li>â€¢ Option C. Heavy meals: While heavy meals can cause discomfort, they are unlikely to cause the specific positional symptoms described.</li><li>â€¢ Option C. Heavy meals:</li><li>â€¢ Option D. Excessive venous pooling at the feet: This might cause symptoms such as swelling and discomfort in the legs but not the specific positional dizziness described.</li><li>â€¢ Option D. Excessive venous pooling at the feet:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Inferior vena cava compression by the gravid uterus in late pregnancy can cause supine hypotensive syndrome, leading to light-headedness and dizziness when lying on the back, which is relieved by lying on the side or walking.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 62-year-old female with history of ovarian carcinoma in the mother achieved menopause with smooth transition. She is on hormone replacement therapy. She developed abdominal pain. On examination, a right adnexal mass was palpable and non-tender. On ultrasound, a 3 X 3 cm smooth cyst in her ovary was noted. What is the next best step? (INICET MAY 2017)", "options": [{"label": "A", "text": "Reassure and advice regular follow up once in 6 months", "correct": false}, {"label": "B", "text": "Confirm USG findings by ordering CT scan", "correct": false}, {"label": "C", "text": "Do an exploratory laparoscopy to visualize the nature of cyst", "correct": false}, {"label": "D", "text": "Do CA-125 levels, if normal advise regular check up", "correct": true}], "correct_answer": "D. Do CA-125 levels, if normal advise regular check up", "question_images": [], "explanation_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-104932.jpg"], "explanation": "<p><strong>Ans. D) Do CA-125 levels, if normal advise regular check up</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The next best step in managing a postmenopausal woman with a small (3 x 3 cm) smooth ovarian cyst is to measure CA-125 levels. CA-125 is a tumor marker used to assess the risk of ovarian cancer, especially in postmenopausal women. Given the benign characteristics of the cyst on ultrasound and the small size, the initial step is to evaluate CA-125 levels:</li><li>â€¢ CA-125 Levels: If the CA-125 levels are normal (less than 35), the patient can be advised to have regular follow-ups. Regular Follow-ups: If CA-125 levels are normal, a transvaginal ultrasound (TVS) should be repeated in 6-12 weeks to monitor the cyst. If the cyst persists but remains benign, yearly TVS is recommended.</li><li>â€¢ CA-125 Levels: If the CA-125 levels are normal (less than 35), the patient can be advised to have regular follow-ups.</li><li>â€¢ CA-125 Levels:</li><li>â€¢ Regular Follow-ups: If CA-125 levels are normal, a transvaginal ultrasound (TVS) should be repeated in 6-12 weeks to monitor the cyst. If the cyst persists but remains benign, yearly TVS is recommended.</li><li>â€¢ Regular Follow-ups:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option A. Reassure and advise regular follow-up once in 6 months: While reassurance is part of the management, initial evaluation with CA-125 is necessary to rule out malignancy before deciding on the follow-up schedule.</li><li>â€¢ Option A. Reassure and advise regular follow-up once in 6 months:</li><li>â€¢ Option B. Confirm USG findings by ordering a CT scan: A CT scan is not the first-line investigation for a simple cyst with benign features. Initial evaluation with CA-125 is more appropriate.</li><li>â€¢ Option B. Confirm USG findings by ordering a CT scan:</li><li>â€¢ Option C. Do an exploratory laparoscopy to visualize the nature of the cyst: This is invasive and not indicated for a small, benign-appearing cyst without other concerning features.</li><li>â€¢ Option C. Do an exploratory laparoscopy to visualize the nature of the cyst:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Simple cysts in the post-menopausal age grp:</li><li>âž¤ â‰¤ 1cm: Considered normal â‰¤ 5 cm: Ca125; if normal, repeat in 6-12 weeks > 6 cm: Surgical evaluation</li><li>âž¤ â‰¤ 1cm: Considered normal</li><li>âž¤ â‰¤ 5 cm: Ca125; if normal, repeat in 6-12 weeks</li><li>âž¤ > 6 cm: Surgical evaluation</li><li>âž¤ Ref: Page no 217, Williams Gynecology 3 rd edition</li><li>âž¤ Ref: Page no 217, Williams Gynecology 3 rd edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "When is dilatation and curettage contraindicated? (NEET PG 2018)", "options": [{"label": "A", "text": "Pelvic inflammatory disease", "correct": true}, {"label": "B", "text": "Ectopic pregnancy", "correct": false}, {"label": "C", "text": "Menstrual irregularities", "correct": false}, {"label": "D", "text": "Endometriosis", "correct": false}], "correct_answer": "A. Pelvic inflammatory disease", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Pelvic inflammatory disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ Pelvic inflammatory disease (PID) includes endometritis, salpingitis, oophoritis, and parametritis. Any interventions like dilatation and curettage (D&C) are contraindicated in active PID due to the risk of exacerbating the infection and causing further complications.</li><li>â€¢ Other options:</li><li>â€¢ Other options:</li><li>â€¢ Option B. Ectopic pregnancy : D&C is not contraindicated in ectopic pregnancy; however, it is not typically performed in its management as it does not provide any benefit for this condition.</li><li>â€¢ Option B. Ectopic pregnancy</li><li>â€¢ Option C. Menstrual irregularities : D&C can be performed to obtain an endometrial biopsy in peri-menopausal women with abnormal uterine bleeding (AUB) if there are no other identifiable causes and if endometrial hyperplasia or malignancy is suspected.</li><li>â€¢ Option C. Menstrual irregularities</li><li>â€¢ Option D. Endometriosis : D&C is not usually performed solely for endometriosis unless there is an associated AUB that needs to be evaluated or treated.</li><li>â€¢ Option D. Endometriosis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ Dilatation and curettage (D&C) is contraindicated in active pelvic inflammatory disease (PID) due to the risk of spreading the infection</li><li>âž¤ Ref: Page 168, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li><li>âž¤ Ref: Page 168, DC Duttaâ€™s Textbook of Gynecology, 6 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 60-year-old woman presented with post-menopausal bleeding. Ultrasonography revealed a mass with feeding vessel as shown in the image below. What is the most likely diagnosis? (NEET PG 2020)", "options": [{"label": "A", "text": "Fibroid uterus", "correct": false}, {"label": "B", "text": "ï»¿ï»¿ï»¿Endometrial polyp", "correct": true}, {"label": "C", "text": "ï»¿ï»¿ï»¿Endometrial carcinoma", "correct": false}, {"label": "D", "text": "ï»¿ï»¿ï»¿Leiomyosarcoma", "correct": false}], "correct_answer": "B. ï»¿ï»¿ï»¿Endometrial polyp", "question_images": ["https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture1.png"], "explanation_images": [], "explanation": "<p><strong>Ans. B) Endometrial polyp</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ The presence of a single feeding vessel in a mass seen on ultrasonography is highly suggestive of an endometrial polyp.</li><li>âž¤ Ref: Page no 460, Williams Gynecology, 3 rd edition</li><li>âž¤ Ref: Page no 460, Williams Gynecology, 3 rd edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management? (INICET MAY 2018)", "options": [{"label": "A", "text": "Immediate termination", "correct": true}, {"label": "B", "text": "Give surfactant and wait till 36 weeks", "correct": false}, {"label": "C", "text": "Do Doppler everyday to check for reversion", "correct": false}, {"label": "D", "text": "Terminate after 37 weeks", "correct": false}], "correct_answer": "A. Immediate termination", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. A) Immediate termination</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The scenario described indicates fetal compromise, specifically with the findings of oligohydramnios (AFI = 5) and absent end-diastolic flow in the umbilical artery Doppler. These are signs of severe placental insufficiency and fetal distress.</li><li>â€¢ Absent or Reversed End-Diastolic Flow: This is a critical finding on Doppler ultrasound indicating severe fetal compromise. The absence of end-diastolic flow in the umbilical artery suggests that the fetus is not receiving adequate blood flow, leading to an increased risk of hypoxia and stillbirth. Management: Immediate Termination: For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</li><li>â€¢ Absent or Reversed End-Diastolic Flow: This is a critical finding on Doppler ultrasound indicating severe fetal compromise. The absence of end-diastolic flow in the umbilical artery suggests that the fetus is not receiving adequate blood flow, leading to an increased risk of hypoxia and stillbirth.</li><li>â€¢ Absent or Reversed End-Diastolic Flow:</li><li>â€¢ Management: Immediate Termination: For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</li><li>â€¢ Management:</li><li>â€¢ Immediate Termination: For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</li><li>â€¢ Immediate Termination: For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</li><li>â€¢ Immediate Termination:</li><li>â€¢ Other Options:</li><li>â€¢ Other Options:</li><li>â€¢ Option B. Give surfactant and wait till 36 weeks: This is not appropriate because the immediate risk to the fetus requires prompt delivery.</li><li>â€¢ Option B. Give surfactant and wait till 36 weeks:</li><li>â€¢ Option C. Do Doppler everyday to check for reversion: Continuous monitoring is insufficient in this scenario as the condition indicates severe fetal distress requiring urgent intervention.</li><li>â€¢ Option C. Do Doppler everyday to check for reversion:</li><li>â€¢ Option D. Terminate after 37 weeks: Waiting until 37 weeks is not appropriate due to the immediate risk of fetal compromise.</li><li>â€¢ Option D. Terminate after 37 weeks:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In cases of severe fetal compromise indicated by absent or reversed end-diastolic flow in the umbilical artery Doppler, especially beyond 34 weeks of gestation, immediate termination of the pregnancy is warranted to prevent fetal hypoxia and potential stillbirth.</li><li>âž¤ Ref: Page no 2141, Williams Obstetrics 26 th edition</li><li>âž¤ Ref: Page no 2141, Williams Obstetrics 26 th edition</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 30-year-old female patient, on treatment for infertility, came with 6 weeks of amenorrhea, abdominal pain, and mild vaginal bleeding. Her beta hCG level was 2800 mlU/mL. On ultrasound, a 3cm mass was seen in the left adnexa. It contained a gestational sac with no fetal cardiac activity. What is the most appropriate management for this patient hCG- Human chorionic gonadotropin? (NEET PG 2021)", "options": [{"label": "A", "text": "Expectant management", "correct": false}, {"label": "B", "text": "Single dose methotrexate", "correct": true}, {"label": "C", "text": "Salpingectomy", "correct": false}, {"label": "D", "text": "Milking of the tube", "correct": false}], "correct_answer": "B. Single dose methotrexate", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans. B) Single dose methotrexate</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>âž¤ Educational Objective:</li><li>âž¤ In a stable patient with an unruptured ectopic pregnancy, beta hCG levels < 5000 IU/L, gestational sac size < 3.5 cm, and no fetal cardiac activity, single-dose methotrexate is the most appropriate management option.</li><li>âž¤ Ref: Page no 378, Williamâ€™s Obstetrics 25 th edition, https://www.nice.org.uk/guidance/ng126</li><li>âž¤ Ref: Page no 378, Williamâ€™s Obstetrics 25 th edition, https://www.nice.org.uk/guidance/ng126</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "When is the quadruple marker test done? (FMGE JULY 2023)", "options": [{"label": "A", "text": "6 â€“ 10 weeks", "correct": false}, {"label": "B", "text": "11 â€“ 14 weeks", "correct": false}, {"label": "C", "text": "16 â€“ 20 weeks", "correct": true}, {"label": "D", "text": "24 â€“ 28 weeks", "correct": false}], "correct_answer": "C. 16 â€“ 20 weeks", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>â€¢ Explanation:</li><li>â€¢ The quadruple marker test is a prenatal screening test performed during the second trimester of pregnancy , typically between 16 and 20 weeks of gestation .</li><li>â€¢ prenatal screening test</li><li>â€¢ second trimester of pregnancy</li><li>â€¢ between 16 and 20 weeks of gestation</li><li>â€¢ This test is used to assess the risk of certain genetic disorders, including Down syndrome (trisomy 21) , trisomy 18, and neural tube defects.</li><li>â€¢ Down syndrome (trisomy 21)</li><li>â€¢ The quadruple marker test measures four specific substances in the mother